id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2014-E-1653-0006,FDA,FDA-2014-E-1653,"Determination of Regulatory Review Period for Purposes of Patent
Extension; SOLX SYSTEM",Notice,Determinations,2017-11-29T05:00:00Z,2017,11,2017-11-29T05:00:00Z,2018-01-30T04:59:59Z,2017-11-29T16:36:24Z,2017-25773,0,0,0900006482cbbd25
FDA-2014-E-1653-0005,FDA,FDA-2014-E-1653,Letter from FDA CDER to the U.S. Patent and Trademark Office,Other,Letter(s),2017-06-05T04:00:00Z,2017,6,2017-06-05T04:00:00Z,,2017-06-05T19:30:08Z,,0,0,09000064826929ab